Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.025
Sell
RSI(14)
45.833
Neutral
STOCH(KDJ)(9,3,3)
30.804
Neutral
ATR(14)
0.095
High Vlolatility
CCI(14)
-63.659
Neutral
Williams %R
75.031
Sell
TRIX(12,20)
-0.165
Sell
StochRSI(14)
61.387
Sell
Search
Immuron Ltd
IMRNAdd to Watchlist
1.090USD
-0.020-1.80%
Close 07-31 16:00（ET）Quotes delayed by 15 min
6.38MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.80%
5 Days
-1.80%
1 Month
+2.83%
6 Months
+17.20%
Year to Date
+42.95%
1 Year
-32.72%
Key Figures
1.120Open
1.135High
11.26KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.19%Turnover Ratio
1.110Prev. Close
1.090Low
7.64KTurnover
LossP/E Static
1.21P/B
0.00%Div Yield TTM
-40.97%ROA
2.39052wk High
0.48Volume Ratio
-5.22MNet Profit
5.85MShares
-0.0345EPS TTM
0.94Beta
-50.65%ROE
0.67652wk Low
4.05%Amplitude
64.02%Gross Margin
6.38MMarket Cap
0.18Reward/Risk
5.18%Risk Rate
Immuron Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
4.000
Target Price
+265.30%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Immuron Ltd
IMRN
1
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.090
Buy
MA10
1.121
Sell
MA20
1.169
Sell
MA50
1.163
Sell
MA100
0.997
Buy
MA200
1.122
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Immuron Ltd Info
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
Ticker SymbolIMRN
CompanyImmuron Ltd
CEOLydeamore (Steven)
Websitehttps://www.immuron.com.au
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Immuron Ltd (IMRN)?
The current price of Immuron Ltd (IMRN) is 1.09.
What is the symbol of Immuron Ltd?
The ticker symbol of Immuron Ltd is IMRN.
What is the 52-week high of Immuron Ltd?
The 52-week high of Immuron Ltd is 2.39.
What is the 52-week low of Immuron Ltd?
The 52-week low of Immuron Ltd is 0.68.
What is the market capitalization of Immuron Ltd?
The market capitalization of Immuron Ltd is 6.38M.
Is Immuron Ltd (IMRN) currently rated as Buy, Hold, or Sell?
According to analysts, Immuron Ltd (IMRN) has an overall rating of Buy, with a price target of 4.00.
What is the Earnings Per Share (EPS TTM) of Immuron Ltd (IMRN)?
The Earnings Per Share (EPS TTM) of Immuron Ltd (IMRN) is -0.59.